(Q51284617)
Statements
1 reference
Exenatide treatment decreases fasting fibroblast growth factor 21 levels in patients with newly diagnosed type 2 diabetes mellitus. (English)
1 reference
Y Hu
J Liu
H Zhang
Y Xu
10 May 2016
1 reference